Skip to main content

Arnau Peñalver Piñol

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Arnau Peñalver Piñol

Institutions of which they are part

Predoctoral researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Projects

Development of Robust and Innovative Vaccine Effectiveness (DRIVE)

IP: Susana Otero Romero
Collaborators: Eva del Amo Moran, Cristina Andrés Vergés, Arnau Peñalver Piñol
Funding agency: The Innovative Medicines Initiative
Funding: 59690
Reference: DRIVE_IMI2-2018_SUBART11
Duration: 07/08/2018 - 30/09/2019

Related news

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

The Lancet Neurology publishes the new criteria, the result of a global expert consensus led by Dr Xavier Montalban.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

Related professionals

Stefan Huemmer

Stefan Huemmer

Main researcher
Translational Molecular Pathology
Read more
Manuel López Paredes

Manuel López Paredes

Head of group
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Maria Vidal Burdeus

Maria Vidal Burdeus

Predoctoral researcher
Cardiovascular Diseases
Read more
Eladia Montserrat Tauste Rubio

Eladia Montserrat Tauste Rubio

Research assistant
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.